Otsuka Pharmaceutical Development & Commercialization, INC.

Pharmaceutical research and development

Based in MD

🤖

AI Overview

With $300K in lobbying spend across 12 quarterly filings, Otsuka Pharmaceutical Development & Commercialization, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2020.

$300K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$240K
2019	$60K
2020	$0

Issues Lobbied

Lobbying Firms

Akin Gump Strauss Hauer & Feld

Lobbyists

Heide Bajnrauh John Jonas Richard Thompson Eli Tomar Matthew Tuten Louis Agnello

Government Agencies Targeted

These are the government entities that Otsuka Pharmaceutical Development & Commercialization, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent, Health Issues

The Innovation Act (H.R. 9); Helping Families in Mental Health Crisis Act (H.R. 2646); Mental Health Reform Act of 2015 (H.R. 1945); Mental Health Awareness and Improvement Act (S. 1893).

H.R. 2646, the Helping Families in Mental Health Crisis Act; H.R. 2690, Strengthening Mental Health In Our Communities Act; H.R. 6, 21st Century Cures initiative; S. 481, Improving Regulatory Transpar